This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Medical Biological Laboratories Co., Ltd., Microbial Chemistry Research Foundation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 43 
1 out of 44 Years Active: 2016
Title: The Innovative Contributions of Sakiko Urano
Introduction
Sakiko Urano is a prominent inventor based in Komagane, Japan. She has made significant strides in the field of cancer research, particularly through her innovative work on antibodies. Her dedication to finding effective treatments for cancer has led to the development of a unique patent that addresses critical challenges in oncology.
Latest Patents
Sakiko Urano holds a patent for an Anti-CXADR antibody. The objective of this invention is to identify a target molecule that is effective for cancer treatments and to provide an antibody that can specifically bind to this molecule. The patent outlines the development of an anticancer agent that comprises the antibody as an active ingredient. Through her research, she identified CXADR as a molecule involved in tumor formation by comparing prostate cancer cell lines. The results demonstrated that an antibody capable of binding to specific regions of the CXADR protein exhibited anti-cancer activity against various cancer cells, including prostate, pancreatic, and colorectal cancer cells.
Career Highlights
Throughout her career, Sakiko Urano has worked with notable organizations such as the Microbial Chemistry Research Foundation and Medical Biological Laboratories Co., Ltd. Her contributions to these institutions have been instrumental in advancing cancer research and developing innovative therapeutic solutions.
Collaborations
Sakiko has collaborated with esteemed colleagues, including Manabu Kawada and Hiroyuki Inoue. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer treatments.
Conclusion
Sakiko Urano's work exemplifies the impact of innovation in the field of cancer research. Her dedication to developing targeted therapies through her patented Anti-CXADR antibody showcases her commitment to improving patient outcomes. Her contributions continue to inspire advancements in medical science and cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile